Synaptogenix Inc (SNPX)

[InTheTrenches]

I disagree...if the improvement is significant enough, trust me, sons/daughters/siblings will DEMAND Bryostatin for their parents/siblings/etc. Sons/daughters/siblings currently DEMAND Memantine--which only delays decline of AD--in spite of their side-effects (diarrhea). If it's possible for patients to improve enough to go from round-the-clock care to assisted living, and remember their kids names, then Bryostatin, in the absence of other competitors, will become the biggest selling drug ever, even if it's IV.

Further (and I haven't investigated this thoroughly yet as it pertains to Bryostatin), $HALO/EnHanze is combined with chemo and other drugs that are currently given IV so that they can be given SC. The uptake on $HALO/EnHanze is becoming significant with many major drug companies. It also has beneficial cost savings for insurance companies (SC vs IV). I believe $HALO/EnHanze charges ~4-5% royalty, but it also can give a competitive advantage, and of course is much easier for patients/medical staff.